480 related articles for article (PubMed ID: 31379811)
1. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
Ameratunga R; Ahn Y; Steele R; Woon ST
Front Immunol; 2019; 10():1541. PubMed ID: 31379811
[No Abstract] [Full Text] [Related]
2. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin.
Ameratunga R; Woon ST; Gillis D; Koopmans W; Steele R
Clin Exp Immunol; 2013 Nov; 174(2):203-11. PubMed ID: 23859429
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Diagnostic Criteria for Common Variable Immunodeficiency Disorders (CVID) in the New Zealand CVID Cohort Study.
Ameratunga R; Longhurst H; Steele R; Woon ST
Clin Rev Allergy Immunol; 2021 Oct; 61(2):236-244. PubMed ID: 34236581
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Efficacy and Safety of Hizentra® in Patients with Primary Immunodeficiency in Japan, Europe, and the United States: a Review of 7 Phase 3 Trials.
Jolles S; Rojavin MA; Lawo JP; Nelson R; Wasserman RL; Borte M; Tortorici MA; Imai K; Kanegane H
J Clin Immunol; 2018 Nov; 38(8):864-875. PubMed ID: 30415311
[TBL] [Abstract][Full Text] [Related]
5. The outcome of patients with unclassified hypogammaglobulinemia in early childhood.
Kutukculer N; Gulez N
Pediatr Allergy Immunol; 2009 Nov; 20(7):693-8. PubMed ID: 19196447
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin (IVIG) efficiency in women with common variable immunodeficiency (CVID) decreases significantly during pregnancy.
Egawa M; Kanegane H; Imai K; Morio T; Miyasaka N
J Matern Fetal Neonatal Med; 2019 Sep; 32(18):3092-3096. PubMed ID: 29614902
[TBL] [Abstract][Full Text] [Related]
7. Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule.
Hustad NB; Degerud HM; Hjelmerud I; Fraz MSA; Nordøy I; Trøseid M; Fevang B; Aukrust P; Jørgensen SF
Front Immunol; 2021; 12():670547. PubMed ID: 34012453
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiency.
Hagan JB; Fasano MB; Spector S; Wasserman RL; Melamed I; Rojavin MA; Zenker O; Orange JS
J Clin Immunol; 2010 Sep; 30(5):734-45. PubMed ID: 20454851
[TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.
Kasztalska K; Ciebiada M; Cebula-Obrzut B; Górski P
Clin Drug Investig; 2011; 31(5):299-307. PubMed ID: 21473654
[TBL] [Abstract][Full Text] [Related]
10. Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
Scheuerlein P; Pietsch L; Camacho-Ordonez N; Reiser V; Patel S; Burns SO; Warnatz K; Grimbacher B
Front Immunol; 2018; 9():1656. PubMed ID: 30072997
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous Immunoglobulin Therapy for Hypogammaglobulinemia Secondary to Malignancy or Related Drug Therapy.
Windegger TM; Lambooy CA; Hollis L; Morwood K; Weston H; Fung YL
Transfus Med Rev; 2017 Jan; 31(1):45-50. PubMed ID: 27450021
[TBL] [Abstract][Full Text] [Related]
12. Clinical and immunological features of 44 common variable immunodeficiency patients: the experience of a single center in Turkey.
Nepesov S; Aygun FD; Firtina S; Cokugras H; Camcioglu Y
Allergol Immunopathol (Madr); 2020; 48(6):675-685. PubMed ID: 32299645
[TBL] [Abstract][Full Text] [Related]
13. Home therapy with subcutaneous immunoglobulins for patients with primary immunodeficiency diseases.
Haddad É; Barnes D; Kafal A
Transfus Apher Sci; 2012 Jun; 46(3):315-21. PubMed ID: 22503304
[TBL] [Abstract][Full Text] [Related]
14. Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia.
Spadaro G; Pecoraro A; De Renzo A; Della Pepa R; Genovese A
Clin Immunol; 2016 May; 166-167():103-4. PubMed ID: 27063866
[TBL] [Abstract][Full Text] [Related]
15. [Subcutaneous gammaglobulin in common variable immunodeficiency. First experience in Spain].
Maroto Hernando M; Soler Palacín P; Martin Nalda N; Oliveras Arenas M; Español Boren T; Figueras Nadal C
An Pediatr (Barc); 2009 Feb; 70(2):111-9. PubMed ID: 19217565
[TBL] [Abstract][Full Text] [Related]
16. Immunological and clinical features of pediatric patients with primary hypogammaglobulinemia in Taiwan.
Wang LJ; Yang YH; Lin YT; Chiang BL
Asian Pac J Allergy Immunol; 2004 Mar; 22(1):25-31. PubMed ID: 15366655
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of subcutaneous versus intravenous IgG replacement therapy in pediatric patients with primary immunodeficiency diseases: a multicenter study in Argentina.
Bezrodnik L; Gómez Raccio A; Belardinelli G; Regairaz L; Díaz Ballve D; Seminario G; Moreira I; Riganti C; Cantisano C; Díaz H; Di Giovanni D
J Clin Immunol; 2013 Oct; 33(7):1216-22. PubMed ID: 23846854
[TBL] [Abstract][Full Text] [Related]
18. Intravenous and subcutaneous immunoglobulin G replacement therapy.
Bonilla FA
Allergy Asthma Proc; 2016 Nov; 37(6):426-431. PubMed ID: 27931296
[TBL] [Abstract][Full Text] [Related]
19. Disseminated bronchiectasis in an adult with common variable immunodeficiency.
Zea-Vera AF; Agudelo-Rojas OL
Colomb Med (Cali); 2015; 46(1):47-50. PubMed ID: 26019385
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal study of intravenous versus subcutaneous immunoglobulin replacement therapy in hematological malignancy.
Windegger TM; English J; Weston H; Morwood K; Kynn M; Scuffham P; Fung YL
Asia Pac J Clin Oncol; 2021 Dec; 17(6):546-554. PubMed ID: 33460509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
